Issue 63, 2019

Linear PVA–DTPA–Gd conjugate for magnetic resonance imaging

Abstract

In this study, we report the preparation and characterization of the PVA–DTPA–Gd conjugate as a potential MRI contrast agent (CA). The r1 value and the r2/r1 ratio were about 5.6 mM−1 s−1 and 1.31, respectively. In vitro toxicity studies not only demonstrated that the polymeric system possessed good biocompatibility, but also proved that the conjugate could be an attractive candidate for CA.

Graphical abstract: Linear PVA–DTPA–Gd conjugate for magnetic resonance imaging

Supplementary files

Article information

Article type
Paper
Submitted
20 Jul 2019
Accepted
29 Oct 2019
First published
12 Nov 2019
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2019,9, 37052-37056

Linear PVA–DTPA–Gd conjugate for magnetic resonance imaging

W. Xu, Z. Lin, G. Li, H. Long, M. Du, G. Fu and L. Pu, RSC Adv., 2019, 9, 37052 DOI: 10.1039/C9RA05607F

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements